Tandem Diabetes Care launched a new predictive feature designed to help reduce the frequency and duration of low-glucose events by pausing insulin delivery. The technology is available as a free ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 ...
Medical Device Network on MSN
FDA clears Android version of Tandem Mobi mobile application
The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...
An update is available for Tandem’s t:connect iOS mobile app that should prevent it from prematurely draining insulin pump batteries. An update is available for Tandem’s t:connect iOS mobile app that ...
The technology went through the FDA’s new interoperability pathway, which encourages device-makers to build products that can be used across systems or platforms. Both Tandem Diabetes’ software and ...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app.
CHICAGO, Dec 13 (Reuters) - The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's TNDM.O software program that uses readings from a continuous glucose monitor to ...
A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback